Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|February 4, 2014
Budesonide multi-matrix system formulation for treating ulcerative colitisCosimo Prantera, Maria Lia ScribanoWorld Journal of Gastroenterology|November 22, 2013
Rifaximin and Crohn's diseaseCosimo Prantera, Maria Lia ScribanoCurrent Opinion in Gastroenterology|May 16, 2009
Antibiotics and probiotics in inflammatory bowel disease: why, when, and howCosimo Prantera, Maria Lia ScribanoWorld Journal of Gastroenterology|February 23, 2013
Use of antibiotics in the treatment of Crohn's diseaseMaria Lia Scribano, Cosimo PranteraDigestive Diseases (Basel, Switzerland)|November 20, 2013
Antibiotics and inflammatory bowel diseasesMaria Lia Scribano, Cosimo PranteraGastroenterology|December 14, 2011
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's diseaseCosimo Prantera, Herbert Lochs, Maria Grimaldi, et al.Digestive Diseases and Sciences|October 19, 2020
Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?Maria Lia ScribanoMini Reviews in Medicinal Chemistry|July 24, 2015
Role of Rifaximin in Inflammatory Bowel Disease TreatmentMaria Lia ScribanoWorld Journal of Gastroenterology|June 23, 2018
Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidenceMaria Lia ScribanoWorld Journal of Gastroenterology|September 19, 2009
5-ASA in ulcerative colitis: improving treatment complianceCosimo Prantera, Marina RizziPageof 5